NASDAQ
Poniard Pharmaceuticals, Inc. (PARD) has a free cash flow growth of -1.43% as of Friday, May 29, 2026. This represents a 106.24% decrease compared to its 12-month average of 22.84%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.